Drugs / Opipramol
Opipramol
also known as
G-33040 · Insidon · NSC-169867 · Opipramol dihydrochloride · Opipramol dura · Opipramol hcl · OPIPRAMOL HYDROCHLORIDE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03065998 Comparator | Mar 2017 → Jan 2018 | substance abuse | Ministry of Health, Israel | Unknown | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Opipramol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02374567 ↗ |
| Known as | G-33040 | ChEMBL registry synonym — accepted as the source's own label CHEMBL370753 ↗ |
| Known as | Insidon | ChEMBL registry synonym — accepted as the source's own label CHEMBL370753 ↗ |
| Known as | NSC-169867 | ChEMBL registry synonym — accepted as the source's own label CHEMBL370753 ↗ |
| Known as | Opipramol dihydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL370753 ↗ |
| Known as | Opipramol dura | ChEMBL registry synonym — accepted as the source's own label CHEMBL370753 ↗ |
| Known as | Opipramol hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL370753 ↗ |
| Known as | OPIPRAMOL HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL370753 ↗ |
| Action | Activate | “Opipramol is a selective agonist for sigma-1 receptor.” NCT03065998 ↗ |
| Modality | Small molecule | — CHEMBL370753 ↗ |